基于肠道微生物群的肠易激综合征治疗方法
Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.
作者信息
Stern Emily K, Brenner Darren M
机构信息
Division of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
出版信息
Clin Transl Gastroenterol. 2018 Feb 15;9(2):e134. doi: 10.1038/ctg.2018.2.
Abstract
Irritable bowel syndrome (IBS) is a common, heterogeneous disorder characterized by abdominal pain associated with changes in bowel habits. The pathogenesis of IBS is multifactorial and may relate to alterations in the gut microbiota, changes in visceral sensation and motility, and genetic and environmental factors. Administration of systemic antibiotics may increase the risk of IBS by altering gastrointestinal homeostasis. Therapeutic interventions for IBS with diarrhea that are thought to target alterations in the gut microbiota include the nonsystemic antibiotic rifaximin, the medical food serum-derived bovine immunoglobulin, prebiotics, probiotics, and dietary modification. SYN-010 is a modified-release statin formulation that reduces methane production by Methanobrevibacter smithii and is currently in development for the treatment of patients with constipation-predominant IBS. Use of these interventions in the management of patients with IBS may function to restore a healthy gut microbiota and ameliorate symptoms of IBS.
摘要
肠易激综合征（IBS）是一种常见的异质性疾病，其特征为腹痛并伴有排便习惯改变。IBS的发病机制是多因素的，可能与肠道微生物群的改变、内脏感觉和运动的变化以及遗传和环境因素有关。全身性抗生素的使用可能通过改变胃肠道稳态而增加患IBS的风险。被认为针对肠道微生物群改变的腹泻型IBS治疗干预措施包括非全身性抗生素利福昔明、医用食品血清来源的牛免疫球蛋白、益生元、益生菌和饮食调整。SYN-010是一种缓释他汀制剂，可减少史氏甲烷短杆菌产生甲烷，目前正在开发用于治疗以便秘为主的IBS患者。在IBS患者管理中使用这些干预措施可能有助于恢复健康的肠道微生物群并改善IBS症状。
相似文献
1
Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.基于肠道微生物群的肠易激综合征治疗方法
Clin Transl Gastroenterol. 2018 Feb 15;9(2):e134. doi: 10.1038/ctg.2018.2.
2
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.肠道微生物群的调节：聚焦于肠易激综合征的治疗
Postgrad Med. 2017 Nov;129(8):872-888. doi: 10.1080/00325481.2017.1383819. Epub 2017 Oct 13.
3
Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin.腹泻型肠易激综合征的短程疗法：了解利福昔明的作用机制、对肠道微生物群的影响以及安全性和耐受性
Clin Exp Gastroenterol. 2018 Sep 24;11:335-345. doi: 10.2147/CEG.S167031. eCollection 2018.
4
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.便秘型肠易激综合征（IBS-C）：不同营养模式对肠道菌群失调和症状的影响。
Nutrients. 2023 Mar 28;15(7):1647. doi: 10.3390/nu15071647.
5
Irritable bowel syndrome, gut microbiota and probiotics.肠易激综合征、肠道微生物群和益生菌。
J Neurogastroenterol Motil. 2011 Jul;17(3):252-66. doi: 10.5056/jnm.2011.17.3.252. Epub 2011 Jul 13.
6
Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in , Which Is Associated with Higher Methane Production.肠易激综合征，尤其是以便秘为主型，涉及[此处原文缺失具体内容]增加，这与更高的甲烷产生有关。
Gut Liver. 2016 Nov 15;10(6):932-938. doi: 10.5009/gnl15588.
7
Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome.与腹泻型肠易激综合征相关的粪便微生物群改变
Front Microbiol. 2018 Jul 25;9:1600. doi: 10.3389/fmicb.2018.01600. eCollection 2018.
8
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?抗生素、肠道微生物群与肠易激综合征：它们之间有什么关系？
World J Gastroenterol. 2022 Mar 28;28(12):1204-1219. doi: 10.3748/wjg.v28.i12.1204.
9
Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review.利福昔明在肠易激综合征患者中的作用机制及治疗益处：一项叙述性综述
Therap Adv Gastroenterol. 2020 Jan 23;13:1756284819897531. doi: 10.1177/1756284819897531. eCollection 2020.
10
The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review.肠道微生物群在肠易激综合征病理生理学及治疗中的作用：一项系统评价
Cureus. 2022 Aug 16;14(8):e28064. doi: 10.7759/cureus.28064. eCollection 2022 Aug.
引用本文的文献
1
Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.炎症性前列腺炎合并腹泻型肠易激综合征及其与精浆中免疫调节因子失衡的相关性：新型联合治疗
Diseases. 2024 Oct 18;12(10):260. doi: 10.3390/diseases12100260.
2
Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review.益生菌用于缓解肠易激综合征症状的有效性：一项系统评价。
Cureus. 2024 Apr 15;16(4):e58306. doi: 10.7759/cureus.58306. eCollection 2024 Apr.
3
Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time.肠易激综合征：同时治疗肠道与大脑/精神
Cureus. 2023 Aug 13;15(8):e43404. doi: 10.7759/cureus.43404. eCollection 2023 Aug.
4
Assessing the relationship between gut microbiota and irritable bowel syndrome: a two-sample Mendelian randomization analysis.评估肠道微生物群与肠易激综合征的关系：两样本孟德尔随机分析。
BMC Gastroenterol. 2023 May 12;23(1):150. doi: 10.1186/s12876-023-02791-7.
5
Gastrointestinal problems, mechanisms and possible therapeutic directions in Gulf war illness: a mini review.海湾战争病中的胃肠道问题、机制和可能的治疗方向：小型综述。
Mil Med Res. 2021 Sep 9;8(1):50. doi: 10.1186/s40779-021-00341-4.
6
Global research trends in the microbiome related to irritable bowel syndrome: A bibliometric and visualized study.全球与肠易激综合征相关的微生物组研究趋势：文献计量学和可视化研究。
World J Gastroenterol. 2021 Apr 7;27(13):1341-1353. doi: 10.3748/wjg.v27.i13.1341.
7
(Patho-)Physiology of Na/H Exchangers (NHEs) in the Digestive System.消化系统中钠/氢交换体（NHEs）的（病理）生理学
Front Physiol. 2020 Jan 15;10:1566. doi: 10.3389/fphys.2019.01566. eCollection 2019.
8
Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort.肠微生物宏基因组途径的变化与 IBS 队列中吸收不良糖消除后的临床结果相关。
Gut Microbes. 2020 May 3;11(3):620-631. doi: 10.1080/19490976.2019.1686322. Epub 2019 Dec 6.
9
Metabolic Trifecta After Pancreatitis: Exocrine Pancreatic Dysfunction, Altered Gut Microbiota, and New-Onset Diabetes.胰腺炎后的代谢三联征：外分泌胰腺功能障碍、肠道微生物群改变和新发糖尿病。
Clin Transl Gastroenterol. 2019 Oct;10(10):e00086. doi: 10.14309/ctg.0000000000000086.
10
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome.肠道真菌群在肠易激综合征中的潜在作用
Front Microbiol. 2019 Aug 21;10:1894. doi: 10.3389/fmicb.2019.01894. eCollection 2019.
本文引用的文献
1
Irritable Bowel Syndrome.肠易激综合征
N Engl J Med. 2017 Jun 29;376(26):2566-2578. doi: 10.1056/NEJMra1607547.
2
Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.利福昔明重复治疗肠易激综合征：粪便微生物对抗生素的敏感性无临床显著变化。
Dig Dis Sci. 2017 Sep;62(9):2455-2463. doi: 10.1007/s10620-017-4598-7. Epub 2017 Jun 6.
3
Controversies and Recent Developments of the Low-FODMAP Diet.低聚果糖饮食的争议与最新进展
Gastroenterol Hepatol (N Y). 2017 Jan;13(1):36-45.
4
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.与健康对照相比，肠易激综合征患者肠道微生物群分子特征的改变：一项系统评价和荟萃分析。
Dig Liver Dis. 2017 Apr;49(4):331-337. doi: 10.1016/j.dld.2017.01.142. Epub 2017 Jan 21.
5
Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts.内脏高敏与功能性胃肠病的胃肠道症状严重程度相关：来自五个不同患者队列的一致发现。
Gut. 2018 Feb;67(2):255-262. doi: 10.1136/gutjnl-2016-312361. Epub 2017 Jan 19.
6
Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.感染性肠炎后肠易激综合征的患病率、危险因素及结局：一项系统评价和荟萃分析
Gastroenterology. 2017 Apr;152(5):1042-1054.e1. doi: 10.1053/j.gastro.2016.12.039. Epub 2017 Jan 6.
7
Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.胃肠道神经肌肉装置：肠道微生物群被低估的靶点。
World J Gastroenterol. 2016 Dec 7;22(45):9871-9879. doi: 10.3748/wjg.v22.i45.9871.
8
The Human Intestinal Microbiome in Health and Disease.健康与疾病中的人类肠道微生物群
N Engl J Med. 2016 Dec 15;375(24):2369-2379. doi: 10.1056/NEJMra1600266.
9
Human Intestinal Barrier Function in Health and Disease.健康与疾病状态下的人类肠道屏障功能
Clin Transl Gastroenterol. 2016 Oct 20;7(10):e196. doi: 10.1038/ctg.2016.54.
10
A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.一项比较低FODMAP饮食与改良版英国国家卫生与临床优化研究所（NICE）指南对美国患有腹泻型肠易激综合征（IBS-D）成年人疗效的随机对照试验。
Am J Gastroenterol. 2016 Dec;111(12):1824-1832. doi: 10.1038/ajg.2016.434. Epub 2016 Oct 11.
Zotero 插件